13/04/2022.

Melanoma has a poor prognosis with median survival of 6-9 months in the absence of timely diagnosis and treatment.

11/04/2022.

Intégrer l’intelligence artificielle au domaine médical, c’est se poser les bonnes questions, notamment au niveau éthique. 

7/04/2022.

The second issue of the iToBoS newsletter was released!!

4/04/2022.

On March 30th, scientists from the International Agency for Research on Cancer published a study on the Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040.

1/04/2022.

iToBoS project aims to provide new opportunities and added value to society in terms of novel health solutions, patient care, innovation, technical improvements and economic development.

31/03/2022.

iToBoS was presented in the framework of a course of the Academia Española de Dermatologia y Venereologia (AEDV) in Barcelona, Spain, on March 31, 2022. 

31/03/2022.

iToBoS project has launched ai4pa (Artificial Intelligence For Patient Advocates) consisting in a training module oriented to patient advocates that serves as an introduction to transparent and explainable AI and its policy context.

30/03/2022.

We present an overview of the online datasets meant for machine learning algorithms. As the saying goes, “An algorithm can be only as good as the data set”. 

29/03/2022.

Until a few years ago, regulations and standards existed around the handling and use of certain types of data, including the General Data Protection Regulation (GDPR) in Europe, HIPAA and PCI-DSS in the United States, the Canadian Consumer Privacy Protection Act (CPPA) and many more.

28/03/2022.

The aim of the Deliverable 12.7. Exploitation and Business Plan is to present the common strategy for exploiting the results (both individually and collectively) of the project to ensure that they are owned by the relevant stakeholders during and after the life of the project.